No wheat, no gluten, no soybeans, no dairy, no egg, no fish/shellfish, no peanuts/tree nuts.
This supports the appetite-control benefits of GLP-1 medication
Suspected side effects should be reported through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)
Some patients may experience hypoglycaemia (low blood sugar), particularly when Rybelsus is used in combination with insulin or sulphonylureas
Ebrahimi-Mameghani, M., Clinical effectiveness of -lipoic acid, myo-inositol and propolis supplementation on metabolic profiles and liver function in obese patients with NAFLD: A randomized controlled clinical trial
Kibbe, C., Chen, J., Xu, G., Jing, G